You are here

Study Evaluating Prevenar Vaccine in Healthy Infants

Last updated on February 18, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
42-100 days
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male and female children 2 months of age (42 to 100 days) in good health.

- An informed consent must be signed by a parent or legal guardian following a detailed
explanation of participation in the study.

- Infants whose parent(s)/guardian(s) will be available for the entire study period.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hypersensitivity to any component of the vaccine, including diphtheria toxoid

- Infants with thrombocytopenia or any coagulation disorder that would contraindicate
intramuscular injection

- Infants with known or suspected impairment of immunologic functions including HIV or
those receiving immunosuppressive therapy.

Other exclusions apply.

NCT00276107
Pfizer
Completed
Study Evaluating Prevenar Vaccine in Healthy Infants

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now